Nasal Sprays Market Nasal Sprays Market Shows Strong Potential Amid Health Awareness The nasal sprays market is evolving fast, driv ...

Latest updates on Covid-19 in India and Southeast Asia, including vaccination status, variants, and expert advice on booster ...

After rapid expansion, signs of a slowdown raise questions about future opportunities in the sector When it emerged that ...

AstraZeneca plans to sell it online directly to consumers. Related story: CDC recommends nasal flu spray for children Researchers expect other vaccines will follow. Some are already investigating ...

open image in gallery An image shows AstraZeneca’s nasal spray FluMist. FluMist is the first influenza vaccine approved to be administered by one’s self or using a caregiver. The Food and Drug ...

The FDA has approved FluMist (AstraZeneca) for self-administration by adults up to age 49 years or for caregiver administration for children aged 2 to 17 years, making it the first self ...

23, 2024 – The FDA on Friday approved FluMist, a nasal spray flu vaccine that ... An online pharmacy will soon offer the vaccine. AstraZeneca said that after completing a screening process ...

The nasal spray vaccine, called FluMist, still needs to be prescribed by a medical provider. But since nearly everyone aged two through 49 is eligible, FluMist’s maker (AstraZeneca) is setting ...

In a first, the United States Food and Drug Administration (FDA) on Friday, September 20, 2024, approved a nasal spray flu vaccine for self-administration. Starting next fall, AstraZeneca's ...

But he said he hoped it would lead to increased awareness, potentially through more marketing from AstraZeneca or more research into additional intranasal vaccines that are easier to get.